In a Swedish patient cohort, the abundance of CD163+ TAMs in biopsies was correlated with earlier recurrence and poor survival [117], with contradicting results in a Greek patient cohort, where lower tumor grade, fewer lymph node metastases, and improved survival were correlated with increased stromal infiltration of CD163+ TAMs [118]. The gene discussed is CD163; the disease is neoplasm.